All Cosmos Bio-Tech Holding Corporation (TPE:4148)

TPE:4148 Revenue

All Cosmos Bio-Tech Holding had revenue of 527.66M TWD in the quarter ending March 31, 2026, a decrease of -3.70%. This brings the company's revenue in the last twelve months to 2.93B, up 17.95% year-over-year. In the year 2025, All Cosmos Bio-Tech Holding had annual revenue of 2.95B with 19.95% growth.

• Revenue (ttm): 2.93B
• Revenue Growth: +17.95%
• P/S Ratio: 0.75
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.19B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.95B	490.39M	19.95%
Dec 31, 2024	2.46B	-367.95M	-13.02%
Dec 31, 2023	2.83B	-875.74M	-23.65%
Dec 31, 2022	3.70B	1.51B	68.49%
Dec 31, 2021	2.20B	554.54M	33.76%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error